The foundational 1998 paper by the Novo Nordisk team demonstrated equivalent GH release to GHRP-6 with no significant cortisol or prolactin elevation, representing a meaningful clinical advance
What its testing: This study will look at the SGLT-2 inhibitor Invokanas (canagliflozin) effects on body weight in overweight or obese people with type 2 diabetes
Melanotan 2 is perfect for people who want to get a sun-kissed tan without the need for too much sun exposure.
But what dramatic headlines dont tell you is that the actual risk is low, and theres a ton of context missing
Read about these updates: #KidneyHealth #CardiometabolicCare #ADAStandards ADA Recommends SGLT2 Inhibitors and nsMRAs for Type 2 Diabetes and Albuminuria For the first time, the ADA now recommends starting SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) together for people with type 2 diabetes and albuminuria
The absence of marketing authorisation also means that no approved UK product information defines a human dose, indication, contraindication, adverse-effect profile or monitoring programme
